PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.

MLA

Shin, Gu-Choul, et al. “PRKCSH Contributes to TNFSF Resistance by Extending IGF1R Half-Life and Activation in Lung Cancer.” Experimental & Molecular Medicine, vol. 56, no. 1, Feb. 2024, pp. 192–209. EBSCOhost, https://doi.org/10.1038/s12276-023-01147-1.

APA

Shin, G.-C., Lee, H. M., Kim, N., Seo, S.-U., Kim, K. P., & Kim, K.-H. (2024). PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & Molecular Medicine, 56(1), 192–209. https://doi.org/10.1038/s12276-023-01147-1

Chicago

Shin, Gu-Choul, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang Pyo Kim, and Kyun-Hwan Kim. 2024. “PRKCSH Contributes to TNFSF Resistance by Extending IGF1R Half-Life and Activation in Lung Cancer.” Experimental & Molecular Medicine 56 (1): 192–209. doi:10.1038/s12276-023-01147-1.